Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ADVIA Centaur® Digoxin assay

K-Number: K193397 · 2021-07-16

Decision Date2021-07-16
Product CodeKXT
Advisory CommitteeTX
DecisionSubstantially Equivalent

Device Summary

ADVIA Centaur® Digoxin assay is a medical device manufactured by Siemens Healthcare Diagnostics, Inc.. It received FDA 510(k) clearance on 2021-07-16 under approval number K193397. The device is classified under product code KXT. It was reviewed by the TX advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ADVIA Centaur® Digoxin assay?

ADVIA Centaur® Digoxin assay is a medical device that received FDA 510(k) clearance on 2021-07-16. It is manufactured by Siemens Healthcare Diagnostics, Inc.. The 510(k) number is K193397.

When was ADVIA Centaur® Digoxin assay approved by the FDA?

ADVIA Centaur® Digoxin assay received FDA 510(k) clearance on 2021-07-16, under approval number K193397.

What company makes ADVIA Centaur® Digoxin assay?

ADVIA Centaur® Digoxin assay is manufactured by Siemens Healthcare Diagnostics, Inc..

What is the FDA product code for ADVIA Centaur® Digoxin assay?

The FDA product code for ADVIA Centaur® Digoxin assay is KXT.

Other Devices by Siemens Healthcare Diagnostics, Inc.

View all 71 devices →

Related Devices (Code: KXT)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.